Rapid dissolution formulation of a calcium receptor-active compound

Details for Australian Patent Application No. 2004279318 (hide)

Owner Amgen Inc.

Inventors Lawrence, Glen Gary; Lin, Hung-Ren H.; Ju, Tzuchi R.; Alvarez, Francisco J.

Agent Shelston IP

Pub. Number AU-B-2004279318

PCT Pub. Number WO2005/034928

Priority 60/502,219 12.09.03 US

Filing date 10 September 2004

Wipo publication date 21 April 2005

Acceptance publication date 25 February 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 5/18 (2006.01) Drugs for disorders of the endocrine system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/034928 Priority application(s): WO2005/034928

25 February 2010 Application Accepted

  Published as AU-B-2004279318

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279319-Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects

2004279314-Glutamine for use in treating injury